

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.25993548 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.25993548 |
| 3 | fatty acid elongation (GO:0030497) | 6.51463197 |
| 4 | ensheathment of neurons (GO:0007272) | 5.51542022 |
| 5 | axon ensheathment (GO:0008366) | 5.51542022 |
| 6 | myelination (GO:0042552) | 5.51454149 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.45063495 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.34713667 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.33351737 |
| 10 | protein maturation by protein folding (GO:0022417) | 5.24928570 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 5.12532028 |
| 12 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.12532028 |
| 13 | regulation of mitochondrial translation (GO:0070129) | 4.91666784 |
| 14 | establishment of integrated proviral latency (GO:0075713) | 4.79371935 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.77037907 |
| 16 | protein neddylation (GO:0045116) | 4.62795022 |
| 17 | respiratory electron transport chain (GO:0022904) | 4.40051926 |
| 18 | substantia nigra development (GO:0021762) | 4.36373001 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 4.33155358 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 4.32558109 |
| 21 | electron transport chain (GO:0022900) | 4.28300754 |
| 22 | establishment of mitochondrion localization (GO:0051654) | 4.22796930 |
| 23 | establishment of viral latency (GO:0019043) | 4.22196580 |
| 24 | proteasome assembly (GO:0043248) | 4.22190766 |
| 25 | cholesterol biosynthetic process (GO:0006695) | 4.11529030 |
| 26 | negative regulation of neurotransmitter transport (GO:0051589) | 4.04729900 |
| 27 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.01286822 |
| 28 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.99956605 |
| 29 | protein targeting to mitochondrion (GO:0006626) | 3.97483753 |
| 30 | termination of RNA polymerase III transcription (GO:0006386) | 3.96329947 |
| 31 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.96329947 |
| 32 | presynaptic membrane organization (GO:0097090) | 3.80320389 |
| 33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.80096483 |
| 34 | establishment of protein localization to mitochondrion (GO:0072655) | 3.79161719 |
| 35 | oxidative phosphorylation (GO:0006119) | 3.75421108 |
| 36 | oligodendrocyte differentiation (GO:0048709) | 3.73491508 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.68768065 |
| 38 | cytochrome complex assembly (GO:0017004) | 3.66427011 |
| 39 | presynaptic membrane assembly (GO:0097105) | 3.64891478 |
| 40 | viral transcription (GO:0019083) | 3.64760903 |
| 41 | sterol biosynthetic process (GO:0016126) | 3.64709361 |
| 42 | negative regulation of protein localization to cell surface (GO:2000009) | 3.62710862 |
| 43 | regulation of collateral sprouting (GO:0048670) | 3.57936173 |
| 44 | protein localization to mitochondrion (GO:0070585) | 3.56926537 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.56740106 |
| 46 | response to redox state (GO:0051775) | 3.56644495 |
| 47 | myelin maintenance (GO:0043217) | 3.54810535 |
| 48 | cullin deneddylation (GO:0010388) | 3.53936319 |
| 49 | translational termination (GO:0006415) | 3.50626544 |
| 50 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.47761562 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.47761562 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.46646177 |
| 53 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.45822018 |
| 54 | protein deneddylation (GO:0000338) | 3.44727949 |
| 55 | neuron cell-cell adhesion (GO:0007158) | 3.44346975 |
| 56 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.43940649 |
| 57 | creatine metabolic process (GO:0006600) | 3.43790893 |
| 58 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.42449758 |
| 59 | pseudouridine synthesis (GO:0001522) | 3.42084003 |
| 60 | glycerophospholipid catabolic process (GO:0046475) | 3.40676637 |
| 61 | base-excision repair, AP site formation (GO:0006285) | 3.39794628 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.39488122 |
| 63 | rRNA modification (GO:0000154) | 3.38985146 |
| 64 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.36724777 |
| 65 | astrocyte development (GO:0014002) | 3.35446727 |
| 66 | neuronal action potential propagation (GO:0019227) | 3.35302056 |
| 67 | isoprenoid biosynthetic process (GO:0008299) | 3.34157930 |
| 68 | maturation of SSU-rRNA (GO:0030490) | 3.33634654 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.32859213 |
| 70 | cotranslational protein targeting to membrane (GO:0006613) | 3.31809835 |
| 71 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.31629378 |
| 72 | protein targeting to ER (GO:0045047) | 3.29616112 |
| 73 | GTP biosynthetic process (GO:0006183) | 3.28566042 |
| 74 | apical protein localization (GO:0045176) | 3.27801626 |
| 75 | DNA strand elongation (GO:0022616) | 3.27631489 |
| 76 | translational elongation (GO:0006414) | 3.26445554 |
| 77 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.26111788 |
| 78 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.26111788 |
| 79 | NADH dehydrogenase complex assembly (GO:0010257) | 3.26111788 |
| 80 | neurotransmitter uptake (GO:0001504) | 3.25303897 |
| 81 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.23072018 |
| 82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.22701154 |
| 83 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.21326388 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.21326388 |
| 85 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.20933217 |
| 86 | protein localization to endoplasmic reticulum (GO:0070972) | 3.20083394 |
| 87 | ribosomal large subunit biogenesis (GO:0042273) | 3.19744950 |
| 88 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.18746984 |
| 89 | protein complex biogenesis (GO:0070271) | 3.18701191 |
| 90 | nuclear envelope reassembly (GO:0031468) | 3.18250464 |
| 91 | mitotic nuclear envelope reassembly (GO:0007084) | 3.18250464 |
| 92 | positive regulation of action potential (GO:0045760) | 3.17791463 |
| 93 | metallo-sulfur cluster assembly (GO:0031163) | 3.17319195 |
| 94 | iron-sulfur cluster assembly (GO:0016226) | 3.17319195 |
| 95 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.16435827 |
| 96 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.15486529 |
| 97 | translation (GO:0006412) | 3.15180474 |
| 98 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.15173191 |
| 99 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.13540989 |
| 100 | virion attachment to host cell (GO:0019062) | 3.13001873 |
| 101 | adhesion of symbiont to host cell (GO:0044650) | 3.13001873 |
| 102 | cellular component biogenesis (GO:0044085) | 3.11847783 |
| 103 | deoxyribonucleotide catabolic process (GO:0009264) | 3.11279940 |
| 104 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.09350615 |
| 105 | GPI anchor biosynthetic process (GO:0006506) | 3.08264456 |
| 106 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.07825521 |
| 107 | neural nucleus development (GO:0048857) | 3.07168031 |
| 108 | aerobic respiration (GO:0009060) | 3.06866615 |
| 109 | UTP biosynthetic process (GO:0006228) | 3.06804490 |
| 110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.06239097 |
| 111 | adult walking behavior (GO:0007628) | 3.04867535 |
| 112 | amyloid precursor protein metabolic process (GO:0042982) | 3.04321689 |
| 113 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.03651232 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.03651232 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.03651232 |
| 116 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.03316828 |
| 117 | transmission of nerve impulse (GO:0019226) | 3.02957151 |
| 118 | spliceosomal snRNP assembly (GO:0000387) | 3.02903013 |
| 119 | mannosylation (GO:0097502) | 3.02444546 |
| 120 | regulation of catecholamine metabolic process (GO:0042069) | 3.02213544 |
| 121 | regulation of dopamine metabolic process (GO:0042053) | 3.02213544 |
| 122 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.01415107 |
| 123 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.00706733 |
| 124 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.00050929 |
| 125 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.00050929 |
| 126 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.99822875 |
| 127 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.99822875 |
| 128 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.99573791 |
| 129 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.99260462 |
| 130 | mitochondrial transport (GO:0006839) | 2.99141995 |
| 131 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98273797 |
| 132 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.97280456 |
| 133 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.97033372 |
| 134 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.97033372 |
| 135 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.94953525 |
| 136 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.93507814 |
| 137 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.93507814 |
| 138 | cellular response to epinephrine stimulus (GO:0071872) | 2.92457570 |
| 139 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.92444090 |
| 140 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.90521320 |
| 141 | deoxyribose phosphate catabolic process (GO:0046386) | 2.90490060 |
| 142 | peptidyl-cysteine modification (GO:0018198) | 2.89946801 |
| 143 | hydrogen ion transmembrane transport (GO:1902600) | 2.89517244 |
| 144 | photoreceptor cell differentiation (GO:0046530) | 2.88252131 |
| 145 | eye photoreceptor cell differentiation (GO:0001754) | 2.88252131 |
| 146 | asymmetric protein localization (GO:0008105) | 2.85280657 |
| 147 | protein palmitoylation (GO:0018345) | 2.81059728 |
| 148 | GPI anchor metabolic process (GO:0006505) | 2.80070400 |
| 149 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.79173114 |
| 150 | negative regulation of axonogenesis (GO:0050771) | 2.78744323 |
| 151 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.74929346 |
| 152 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.74929346 |
| 153 | peripheral nervous system axon ensheathment (GO:0032292) | 2.73554088 |
| 154 | myelination in peripheral nervous system (GO:0022011) | 2.73554088 |
| 155 | ATP biosynthetic process (GO:0006754) | 2.70527366 |
| 156 | response to epinephrine (GO:0071871) | 2.69807624 |
| 157 | negative regulation of JUN kinase activity (GO:0043508) | 2.68465527 |
| 158 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.67937678 |
| 159 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.67937678 |
| 160 | proton transport (GO:0015992) | 2.67690380 |
| 161 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.62917362 |
| 162 | glial cell development (GO:0021782) | 2.62096225 |
| 163 | hydrogen transport (GO:0006818) | 2.60639756 |
| 164 | neuronal ion channel clustering (GO:0045161) | 2.59368533 |
| 165 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.58525841 |
| 166 | response to methylmercury (GO:0051597) | 2.58429251 |
| 167 | regulation of feeding behavior (GO:0060259) | 2.55107285 |
| 168 | dopamine biosynthetic process (GO:0042416) | 2.53903761 |
| 169 | synaptic vesicle exocytosis (GO:0016079) | 2.52528135 |
| 170 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.51006748 |
| 171 | magnesium ion transport (GO:0015693) | 2.50502810 |
| 172 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49332805 |
| 173 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.47299145 |
| 174 | L-amino acid import (GO:0043092) | 2.46239269 |
| 175 | membrane tubulation (GO:0097320) | 2.45395640 |
| 176 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.45258203 |
| 177 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.44952222 |
| 178 | peripheral nervous system development (GO:0007422) | 2.44474275 |
| 179 | axon development (GO:0061564) | 2.42982612 |
| 180 | microtubule polymerization or depolymerization (GO:0031109) | 2.38979752 |
| 181 | inner mitochondrial membrane organization (GO:0007007) | 2.38013080 |
| 182 | cranial nerve development (GO:0021545) | 2.36489530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.06817989 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.85195897 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.83695332 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.50227888 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.37181519 |
| 6 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.17564319 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.14508691 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12367691 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.03066974 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.96642894 |
| 11 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.57346796 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52072590 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.45357036 |
| 14 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.44548033 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.38415260 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.34418261 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28034747 |
| 18 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.26445786 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25955524 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.24207666 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16134869 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08882183 |
| 23 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.07127785 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03904259 |
| 25 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.03429656 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99480391 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99240020 |
| 28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.97638761 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95713252 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.95084427 |
| 31 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.93773748 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90945487 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.90759488 |
| 34 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.90736063 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89187717 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88054804 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88054804 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.87681598 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85879110 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84432732 |
| 41 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82891868 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79390753 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78744052 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77703283 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76573119 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76461924 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75226857 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74270396 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.72907818 |
| 50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72780184 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72118744 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68111056 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66878064 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.65603499 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65501086 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59671723 |
| 57 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.58076744 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56426398 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54665722 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52469317 |
| 61 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.51563842 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51532855 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51446696 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50786206 |
| 65 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49826509 |
| 66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48829740 |
| 67 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.48747211 |
| 68 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.47849896 |
| 69 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47134989 |
| 70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.45762490 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44789186 |
| 72 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42445718 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42296409 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.41523294 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41424654 |
| 76 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.38599007 |
| 77 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.38526610 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37837225 |
| 79 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37709605 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37074742 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36337462 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.36245001 |
| 83 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35695258 |
| 84 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35151280 |
| 85 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35004033 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34389674 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30654397 |
| 88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30292898 |
| 89 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30238347 |
| 90 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28744493 |
| 91 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28669663 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28175436 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27813200 |
| 94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.27392593 |
| 95 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25161324 |
| 96 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24513885 |
| 97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24428961 |
| 98 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.21350210 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20378096 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17650641 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16404337 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16327177 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14452333 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14073846 |
| 105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13869006 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13805517 |
| 107 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13783087 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12834081 |
| 109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12706735 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11947279 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11896422 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11123681 |
| 113 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09584617 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07703169 |
| 115 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07555684 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05972571 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05456586 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04736522 |
| 119 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04608654 |
| 120 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03385289 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02633422 |
| 122 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02541172 |
| 123 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.02235268 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01690024 |
| 125 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.01360056 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01188455 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00842477 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00054270 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99945810 |
| 130 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99586496 |
| 131 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.98053398 |
| 132 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97666620 |
| 133 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97248257 |
| 134 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96306503 |
| 135 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96144667 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95990324 |
| 137 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95937280 |
| 138 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93971540 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93719017 |
| 140 | * P68_20966046_ChIP-Seq_HELA_Human | 0.92797682 |
| 141 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92600554 |
| 142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92505275 |
| 143 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91782248 |
| 144 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.90887297 |
| 145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89570211 |
| 146 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89536235 |
| 147 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89377797 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89017092 |
| 149 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88879048 |
| 150 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88528494 |
| 151 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88494516 |
| 152 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88345012 |
| 153 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88177263 |
| 154 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88061633 |
| 155 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87964232 |
| 156 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87226435 |
| 157 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87226435 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87203449 |
| 159 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86005181 |
| 160 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85529560 |
| 161 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85513583 |
| 162 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84747775 |
| 163 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83649049 |
| 164 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83447309 |
| 165 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83212251 |
| 166 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82489715 |
| 167 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82282101 |
| 168 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82047860 |
| 169 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81386702 |
| 170 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81099633 |
| 171 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.80860695 |
| 172 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80463152 |
| 173 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80282461 |
| 174 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78225723 |
| 175 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78220687 |
| 176 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78032777 |
| 177 | JUN_21703547_ChIP-Seq_K562_Human | 0.77802116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.38820619 |
| 2 | MP0000920_abnormal_myelination | 3.81643369 |
| 3 | MP0001529_abnormal_vocalization | 3.61727451 |
| 4 | MP0004270_analgesia | 3.36499102 |
| 5 | MP0003186_abnormal_redox_activity | 3.04989945 |
| 6 | MP0008058_abnormal_DNA_repair | 3.04424766 |
| 7 | MP0001905_abnormal_dopamine_level | 3.00156504 |
| 8 | MP0010030_abnormal_orbit_morphology | 2.75498323 |
| 9 | MP0002272_abnormal_nervous_system | 2.68066331 |
| 10 | MP0003123_paternal_imprinting | 2.61573204 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.45979563 |
| 12 | MP0002064_seizures | 2.45035724 |
| 13 | MP0004142_abnormal_muscle_tone | 2.44341714 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.40668466 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.40429887 |
| 16 | MP0003718_maternal_effect | 2.33783514 |
| 17 | MP0009046_muscle_twitch | 2.25441170 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.21401709 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.20975751 |
| 20 | MP0001486_abnormal_startle_reflex | 2.19213620 |
| 21 | MP0010094_abnormal_chromosome_stability | 2.16169727 |
| 22 | MP0006035_abnormal_mitochondrial_morpho | 2.13807454 |
| 23 | MP0009745_abnormal_behavioral_response | 2.12837018 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.10051175 |
| 25 | MP0003111_abnormal_nucleus_morphology | 2.09607897 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 2.09402467 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 2.05423763 |
| 28 | MP0008932_abnormal_embryonic_tissue | 2.03616260 |
| 29 | MP0005171_absent_coat_pigmentation | 2.02172529 |
| 30 | MP0003329_amyloid_beta_deposits | 1.98738838 |
| 31 | MP0003634_abnormal_glial_cell | 1.93194070 |
| 32 | MP0001485_abnormal_pinna_reflex | 1.91282091 |
| 33 | MP0000778_abnormal_nervous_system | 1.90813615 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.83324705 |
| 35 | MP0004742_abnormal_vestibular_system | 1.83022242 |
| 36 | MP0005670_abnormal_white_adipose | 1.82845115 |
| 37 | MP0003786_premature_aging | 1.79839524 |
| 38 | MP0003690_abnormal_glial_cell | 1.74733528 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.74182902 |
| 40 | MP0003121_genomic_imprinting | 1.72922367 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.72902541 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 1.72112657 |
| 43 | MP0003136_yellow_coat_color | 1.71470787 |
| 44 | MP0005409_darkened_coat_color | 1.71156900 |
| 45 | MP0001970_abnormal_pain_threshold | 1.68882887 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.67465903 |
| 47 | MP0002736_abnormal_nociception_after | 1.67368224 |
| 48 | MP0004885_abnormal_endolymph | 1.64333084 |
| 49 | MP0002229_neurodegeneration | 1.63814216 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.60631454 |
| 51 | MP0004147_increased_porphyrin_level | 1.58937507 |
| 52 | MP0003077_abnormal_cell_cycle | 1.58654307 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.57834918 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.56963654 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.55198134 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.51813476 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.50878594 |
| 58 | MP0000955_abnormal_spinal_cord | 1.46885152 |
| 59 | MP0000358_abnormal_cell_content/ | 1.46423908 |
| 60 | MP0003011_delayed_dark_adaptation | 1.45622080 |
| 61 | MP0004924_abnormal_behavior | 1.44417687 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.44417687 |
| 63 | MP0000751_myopathy | 1.41198085 |
| 64 | MP0004043_abnormal_pH_regulation | 1.40370362 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.40056915 |
| 66 | MP0000749_muscle_degeneration | 1.36432736 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.35908305 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.33804442 |
| 69 | MP0005410_abnormal_fertilization | 1.33254994 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.32969017 |
| 71 | MP0002066_abnormal_motor_capabilities/c | 1.31632920 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.31352552 |
| 73 | MP0003632_abnormal_nervous_system | 1.30498080 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.28050026 |
| 75 | MP0008569_lethality_at_weaning | 1.25943255 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.24993968 |
| 77 | MP0002822_catalepsy | 1.24727708 |
| 78 | MP0000747_muscle_weakness | 1.23306700 |
| 79 | MP0002752_abnormal_somatic_nervous | 1.21353725 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 1.19980664 |
| 81 | MP0001963_abnormal_hearing_physiology | 1.18100825 |
| 82 | MP0005330_cardiomyopathy | 1.17618832 |
| 83 | MP0003122_maternal_imprinting | 1.17007220 |
| 84 | MP0004134_abnormal_chest_morphology | 1.15451284 |
| 85 | MP0009697_abnormal_copulation | 1.15361473 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 1.15214859 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.14976596 |
| 88 | MP0002184_abnormal_innervation | 1.13506416 |
| 89 | MP0001293_anophthalmia | 1.07211477 |
| 90 | MP0005165_increased_susceptibility_to | 1.06575469 |
| 91 | MP0003631_nervous_system_phenotype | 1.06446206 |
| 92 | MP0002163_abnormal_gland_morphology | 1.05785665 |
| 93 | MP0000462_abnormal_digestive_system | 1.05078203 |
| 94 | MP0008260_abnormal_autophagy | 1.03377188 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 1.02140572 |
| 96 | MP0001188_hyperpigmentation | 0.98962373 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.98952785 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.97776979 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.96646956 |
| 100 | MP0003787_abnormal_imprinting | 0.96192021 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.95688568 |
| 102 | MP0001764_abnormal_homeostasis | 0.94937837 |
| 103 | MP0008872_abnormal_physiological_respon | 0.93407710 |
| 104 | MP0002938_white_spotting | 0.93213507 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.92103438 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.92024708 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.91788078 |
| 108 | MP0003283_abnormal_digestive_organ | 0.91111317 |
| 109 | MP0002210_abnormal_sex_determination | 0.90311005 |
| 110 | MP0001984_abnormal_olfaction | 0.89989806 |
| 111 | MP0001501_abnormal_sleep_pattern | 0.89475567 |
| 112 | MP0004133_heterotaxia | 0.89214636 |
| 113 | MP0009379_abnormal_foot_pigmentation | 0.88751625 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.88478053 |
| 115 | MP0003938_abnormal_ear_development | 0.87918192 |
| 116 | MP0002152_abnormal_brain_morphology | 0.87292056 |
| 117 | MP0003119_abnormal_digestive_system | 0.86850429 |
| 118 | MP0003633_abnormal_nervous_system | 0.86580951 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.86123448 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.85103382 |
| 121 | MP0000026_abnormal_inner_ear | 0.85008494 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.84509214 |
| 123 | MP0002102_abnormal_ear_morphology | 0.83509511 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.82967837 |
| 125 | MP0005332_abnormal_amino_acid | 0.82881953 |
| 126 | MP0003315_abnormal_perineum_morphology | 0.82591999 |
| 127 | MP0000049_abnormal_middle_ear | 0.81036039 |
| 128 | MP0002254_reproductive_system_inflammat | 0.80504368 |
| 129 | MP0000631_abnormal_neuroendocrine_gland | 0.79308817 |
| 130 | MP0000516_abnormal_urinary_system | 0.78916953 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.78916953 |
| 132 | MP0005253_abnormal_eye_physiology | 0.78095131 |
| 133 | MP0001145_abnormal_male_reproductive | 0.76332619 |
| 134 | MP0005623_abnormal_meninges_morphology | 0.75469427 |
| 135 | MP0005195_abnormal_posterior_eye | 0.74291278 |
| 136 | MP0000653_abnormal_sex_gland | 0.73141924 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.72983275 |
| 138 | MP0003646_muscle_fatigue | 0.72845841 |
| 139 | MP0001542_abnormal_bone_strength | 0.72438274 |
| 140 | MP0008995_early_reproductive_senescence | 0.71748117 |
| 141 | MP0000762_abnormal_tongue_morphology | 0.70889457 |
| 142 | MP0004085_abnormal_heartbeat | 0.70578207 |
| 143 | MP0001929_abnormal_gametogenesis | 0.68537012 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.68104298 |
| 145 | MP0003698_abnormal_male_reproductive | 0.68071731 |
| 146 | MP0002106_abnormal_muscle_physiology | 0.67992186 |
| 147 | MP0005451_abnormal_body_composition | 0.67714538 |
| 148 | MP0001502_abnormal_circadian_rhythm | 0.67190601 |
| 149 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66377069 |
| 150 | MP0001664_abnormal_digestion | 0.64783438 |
| 151 | MP0005499_abnormal_olfactory_system | 0.64676468 |
| 152 | MP0005394_taste/olfaction_phenotype | 0.64676468 |
| 153 | MP0000313_abnormal_cell_death | 0.63009779 |
| 154 | MP0000604_amyloidosis | 0.62187448 |
| 155 | MP0002160_abnormal_reproductive_system | 0.61537041 |
| 156 | MP0005379_endocrine/exocrine_gland_phen | 0.59815078 |
| 157 | MP0005369_muscle_phenotype | 0.59519837 |
| 158 | MP0009278_abnormal_bone_marrow | 0.59463653 |
| 159 | MP0009250_abnormal_appendicular_skeleto | 0.58559185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolysis (HP:0004366) | 4.71927734 |
| 2 | Increased serum pyruvate (HP:0003542) | 4.71927734 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.71860857 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.71860857 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.68284400 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.27257888 |
| 7 | Cerebral hypomyelination (HP:0006808) | 4.18514635 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.17344091 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.13088443 |
| 10 | Mitochondrial inheritance (HP:0001427) | 4.02414929 |
| 11 | Parakeratosis (HP:0001036) | 4.01795169 |
| 12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.94714693 |
| 13 | Leukodystrophy (HP:0002415) | 3.82945692 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.81733566 |
| 15 | Acute encephalopathy (HP:0006846) | 3.78409836 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.64239360 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.54393358 |
| 18 | Myokymia (HP:0002411) | 3.49882822 |
| 19 | Reticulocytopenia (HP:0001896) | 3.44549040 |
| 20 | Pheochromocytoma (HP:0002666) | 3.44101326 |
| 21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.30495157 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.28061321 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.27817146 |
| 24 | Increased CSF lactate (HP:0002490) | 3.27010313 |
| 25 | Peripheral hypomyelination (HP:0007182) | 3.26800263 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 3.21936019 |
| 27 | Neuroendocrine neoplasm (HP:0100634) | 3.20637984 |
| 28 | Exertional dyspnea (HP:0002875) | 2.95113687 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 2.90690679 |
| 30 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.85495275 |
| 31 | Retinal dysplasia (HP:0007973) | 2.80795962 |
| 32 | Hepatic necrosis (HP:0002605) | 2.80622930 |
| 33 | Increased hepatocellular lipid droplets (HP:0006565) | 2.79306293 |
| 34 | Testicular atrophy (HP:0000029) | 2.79276247 |
| 35 | CNS hypomyelination (HP:0003429) | 2.77831172 |
| 36 | Abnormal protein glycosylation (HP:0012346) | 2.66122742 |
| 37 | Abnormal glycosylation (HP:0012345) | 2.66122742 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66122742 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66122742 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.65882234 |
| 41 | Spastic gait (HP:0002064) | 2.64635464 |
| 42 | Focal motor seizures (HP:0011153) | 2.63407869 |
| 43 | Respiratory failure (HP:0002878) | 2.61798362 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.59754950 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.51250722 |
| 46 | Optic disc pallor (HP:0000543) | 2.49290833 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.48973477 |
| 48 | Dysmetria (HP:0001310) | 2.47478967 |
| 49 | Macrocytic anemia (HP:0001972) | 2.45215112 |
| 50 | Akinesia (HP:0002304) | 2.44490042 |
| 51 | Atonic seizures (HP:0010819) | 2.44036172 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.42865276 |
| 53 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35870745 |
| 54 | Split foot (HP:0001839) | 2.33789465 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.33640758 |
| 56 | Lethargy (HP:0001254) | 2.31010503 |
| 57 | Hypoplastic pelvis (HP:0008839) | 2.30485882 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.29023793 |
| 59 | Autoamputation (HP:0001218) | 2.27159696 |
| 60 | CNS demyelination (HP:0007305) | 2.26294121 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.25847443 |
| 62 | Alacrima (HP:0000522) | 2.25429558 |
| 63 | Spastic paraparesis (HP:0002313) | 2.25052067 |
| 64 | Respiratory difficulties (HP:0002880) | 2.24282952 |
| 65 | Colon cancer (HP:0003003) | 2.23866586 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.23411266 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23411266 |
| 68 | Limb dystonia (HP:0002451) | 2.20681736 |
| 69 | Ankle clonus (HP:0011448) | 2.20606579 |
| 70 | Abnormality of the anterior horn cell (HP:0006802) | 2.20604381 |
| 71 | Degeneration of anterior horn cells (HP:0002398) | 2.20604381 |
| 72 | Hyperalaninemia (HP:0003348) | 2.17323614 |
| 73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17323614 |
| 74 | Abnormality of alanine metabolism (HP:0010916) | 2.17323614 |
| 75 | Onion bulb formation (HP:0003383) | 2.16696722 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.14214795 |
| 77 | Exercise intolerance (HP:0003546) | 2.13685412 |
| 78 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12688395 |
| 79 | Pancytopenia (HP:0001876) | 2.12303997 |
| 80 | Cerebral edema (HP:0002181) | 2.11253613 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.09878744 |
| 82 | Hyperglycinemia (HP:0002154) | 2.09161239 |
| 83 | Scanning speech (HP:0002168) | 2.08250591 |
| 84 | Lactic acidosis (HP:0003128) | 2.07853885 |
| 85 | Opisthotonus (HP:0002179) | 2.05651003 |
| 86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04321345 |
| 87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04321345 |
| 88 | Absent septum pellucidum (HP:0001331) | 2.03690173 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.02428794 |
| 90 | Cholecystitis (HP:0001082) | 1.99845164 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.99845164 |
| 92 | Intention tremor (HP:0002080) | 1.99724919 |
| 93 | Vaginal atresia (HP:0000148) | 1.98586791 |
| 94 | Progressive muscle weakness (HP:0003323) | 1.98548291 |
| 95 | Epileptic encephalopathy (HP:0200134) | 1.98291460 |
| 96 | Stridor (HP:0010307) | 1.98219270 |
| 97 | Poor speech (HP:0002465) | 1.98173372 |
| 98 | Abnormal auditory evoked potentials (HP:0006958) | 1.97954148 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.94325463 |
| 100 | Poor suck (HP:0002033) | 1.93452552 |
| 101 | Genital tract atresia (HP:0001827) | 1.93098033 |
| 102 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92909974 |
| 103 | Methylmalonic acidemia (HP:0002912) | 1.92253234 |
| 104 | Abnormal pupillary function (HP:0007686) | 1.92196822 |
| 105 | Muscle fiber splitting (HP:0003555) | 1.92162503 |
| 106 | X-linked dominant inheritance (HP:0001423) | 1.91952249 |
| 107 | Increased serum lactate (HP:0002151) | 1.91349937 |
| 108 | Rough bone trabeculation (HP:0100670) | 1.90940473 |
| 109 | Insidious onset (HP:0003587) | 1.90512210 |
| 110 | Termporal pattern (HP:0011008) | 1.90512210 |
| 111 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.89545510 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.89384055 |
| 113 | Abnormality of renal resorption (HP:0011038) | 1.88863605 |
| 114 | Progressive inability to walk (HP:0002505) | 1.85729186 |
| 115 | Progressive microcephaly (HP:0000253) | 1.85527429 |
| 116 | Postnatal microcephaly (HP:0005484) | 1.85010768 |
| 117 | Delayed CNS myelination (HP:0002188) | 1.84332005 |
| 118 | Abnormality of the septum pellucidum (HP:0007375) | 1.84065325 |
| 119 | Aplastic anemia (HP:0001915) | 1.83639471 |
| 120 | Hypothermia (HP:0002045) | 1.82771366 |
| 121 | Blindness (HP:0000618) | 1.82560667 |
| 122 | Thickened helices (HP:0000391) | 1.80749854 |
| 123 | Hypomagnesemia (HP:0002917) | 1.80639784 |
| 124 | Gliosis (HP:0002171) | 1.78560468 |
| 125 | Hypoplastic left heart (HP:0004383) | 1.78515961 |
| 126 | Diminished movement (HP:0002374) | 1.78143243 |
| 127 | Medial flaring of the eyebrow (HP:0010747) | 1.77971629 |
| 128 | Unsteady gait (HP:0002317) | 1.77568365 |
| 129 | Morphological abnormality of the inner ear (HP:0011390) | 1.77561875 |
| 130 | Clumsiness (HP:0002312) | 1.77118733 |
| 131 | Megalencephaly (HP:0001355) | 1.76818661 |
| 132 | Abnormality of the foot musculature (HP:0001436) | 1.76223039 |
| 133 | Adrenal hypoplasia (HP:0000835) | 1.75605021 |
| 134 | Emotional lability (HP:0000712) | 1.75021330 |
| 135 | Anteriorly placed anus (HP:0001545) | 1.74861850 |
| 136 | Microretrognathia (HP:0000308) | 1.74823336 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.73610427 |
| 138 | Absent thumb (HP:0009777) | 1.73081392 |
| 139 | Muscle fiber atrophy (HP:0100295) | 1.72686512 |
| 140 | Hypoglycemic coma (HP:0001325) | 1.71594124 |
| 141 | Gait imbalance (HP:0002141) | 1.70910799 |
| 142 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.70772349 |
| 143 | Increased muscle lipid content (HP:0009058) | 1.70633326 |
| 144 | Increased circulating renin level (HP:0000848) | 1.69703665 |
| 145 | Abnormality of urine glucose concentration (HP:0011016) | 1.69574035 |
| 146 | Glycosuria (HP:0003076) | 1.69574035 |
| 147 | Partial duplication of thumb phalanx (HP:0009944) | 1.69475559 |
| 148 | Sclerocornea (HP:0000647) | 1.69184760 |
| 149 | Synostosis involving the elbow (HP:0003938) | 1.68691159 |
| 150 | Humeroradial synostosis (HP:0003041) | 1.68691159 |
| 151 | Delusions (HP:0000746) | 1.68146078 |
| 152 | Abnormality of magnesium homeostasis (HP:0004921) | 1.67478941 |
| 153 | Upper limb muscle weakness (HP:0003484) | 1.66976022 |
| 154 | Congenital, generalized hypertrichosis (HP:0004540) | 1.62747731 |
| 155 | Abnormality of serum amino acid levels (HP:0003112) | 1.62485520 |
| 156 | Cleft eyelid (HP:0000625) | 1.61967475 |
| 157 | Oligomenorrhea (HP:0000876) | 1.61767589 |
| 158 | Hyperglycinuria (HP:0003108) | 1.60930457 |
| 159 | Myoglobinuria (HP:0002913) | 1.55940707 |
| 160 | Cerebral palsy (HP:0100021) | 1.54318463 |
| 161 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.52985372 |
| 162 | Rhabdomyolysis (HP:0003201) | 1.50149981 |
| 163 | Sparse eyelashes (HP:0000653) | 1.48984423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 6.71045145 |
| 2 | STK39 | 5.16800693 |
| 3 | NME2 | 4.14404694 |
| 4 | OXSR1 | 3.93476133 |
| 5 | CDK19 | 2.93679793 |
| 6 | BCKDK | 2.85802292 |
| 7 | BCR | 2.72757649 |
| 8 | LIMK1 | 2.55421733 |
| 9 | ZAK | 2.54433000 |
| 10 | PRPF4B | 2.35498747 |
| 11 | WNK4 | 2.32596158 |
| 12 | CASK | 2.32038908 |
| 13 | TESK2 | 2.27528802 |
| 14 | PNCK | 2.15683909 |
| 15 | TNIK | 2.13508364 |
| 16 | EPHB1 | 2.13288777 |
| 17 | CDC7 | 2.08961148 |
| 18 | MAPKAPK5 | 2.03214819 |
| 19 | UHMK1 | 1.98346897 |
| 20 | KDR | 1.96838607 |
| 21 | PBK | 1.91866761 |
| 22 | PKN1 | 1.89973378 |
| 23 | STK16 | 1.86774739 |
| 24 | CSNK1G3 | 1.84210062 |
| 25 | MET | 1.79087386 |
| 26 | ARAF | 1.77695889 |
| 27 | MUSK | 1.73275020 |
| 28 | NUAK1 | 1.71949722 |
| 29 | DAPK1 | 1.66393687 |
| 30 | MAP3K11 | 1.63738348 |
| 31 | MST4 | 1.63533960 |
| 32 | CAMK2B | 1.56782343 |
| 33 | NEK1 | 1.48886347 |
| 34 | ROCK2 | 1.45390420 |
| 35 | NTRK1 | 1.44206540 |
| 36 | NEK6 | 1.43278299 |
| 37 | PLK3 | 1.43263269 |
| 38 | WNK1 | 1.43172042 |
| 39 | CSNK1A1L | 1.42019954 |
| 40 | NME1 | 1.40808026 |
| 41 | CAMK2D | 1.39343715 |
| 42 | SRPK1 | 1.37521889 |
| 43 | MAP4K2 | 1.33660645 |
| 44 | CSNK1G2 | 1.28040127 |
| 45 | TAF1 | 1.27318276 |
| 46 | ABL2 | 1.26557580 |
| 47 | CSNK1G1 | 1.23842438 |
| 48 | MARK1 | 1.23050164 |
| 49 | DYRK2 | 1.17691207 |
| 50 | EPHA4 | 1.16889864 |
| 51 | FGR | 1.15901741 |
| 52 | MAP3K12 | 1.13542591 |
| 53 | TTK | 1.12143393 |
| 54 | AURKA | 1.11276246 |
| 55 | PHKG2 | 1.10878909 |
| 56 | PHKG1 | 1.10878909 |
| 57 | CDK14 | 1.08732293 |
| 58 | BUB1 | 1.08576477 |
| 59 | CAMK2G | 1.07941831 |
| 60 | PLK1 | 1.04546961 |
| 61 | GRK7 | 1.02315442 |
| 62 | SGK223 | 0.98068479 |
| 63 | SGK494 | 0.98068479 |
| 64 | PLK4 | 0.96781632 |
| 65 | LMTK2 | 0.96225923 |
| 66 | CDK18 | 0.94883845 |
| 67 | CAMK2A | 0.94666043 |
| 68 | CDK15 | 0.94540413 |
| 69 | ICK | 0.93743537 |
| 70 | BRSK1 | 0.93121791 |
| 71 | FGFR2 | 0.88976673 |
| 72 | GRK5 | 0.87771826 |
| 73 | MYLK | 0.86812164 |
| 74 | CDK11A | 0.86721316 |
| 75 | CDK5 | 0.85139985 |
| 76 | MAPKAPK3 | 0.83847376 |
| 77 | CCNB1 | 0.82765406 |
| 78 | CHEK2 | 0.82029935 |
| 79 | ADRBK2 | 0.79906908 |
| 80 | PAK6 | 0.79266811 |
| 81 | BMPR1B | 0.78136653 |
| 82 | OBSCN | 0.78026514 |
| 83 | CDK8 | 0.77386073 |
| 84 | EIF2AK1 | 0.75306115 |
| 85 | PRKCE | 0.74892489 |
| 86 | MAPK13 | 0.74779494 |
| 87 | MINK1 | 0.72772214 |
| 88 | PAK3 | 0.72624896 |
| 89 | CLK1 | 0.72322718 |
| 90 | AURKB | 0.71673003 |
| 91 | MAP2K7 | 0.71474630 |
| 92 | NTRK3 | 0.70795432 |
| 93 | BRAF | 0.69423361 |
| 94 | TIE1 | 0.67414829 |
| 95 | ATR | 0.65309734 |
| 96 | GRK1 | 0.65080567 |
| 97 | PLK2 | 0.64263515 |
| 98 | DAPK2 | 0.63794908 |
| 99 | VRK1 | 0.63164556 |
| 100 | MARK2 | 0.58697047 |
| 101 | PAK1 | 0.57603604 |
| 102 | PDK2 | 0.57070137 |
| 103 | LRRK2 | 0.56988684 |
| 104 | PAK4 | 0.56819924 |
| 105 | NTRK2 | 0.56064427 |
| 106 | DAPK3 | 0.55787153 |
| 107 | INSRR | 0.54855802 |
| 108 | ILK | 0.53859190 |
| 109 | CSNK2A2 | 0.53833060 |
| 110 | EPHA2 | 0.53813303 |
| 111 | TLK1 | 0.53227767 |
| 112 | PRKCI | 0.52683083 |
| 113 | TAOK2 | 0.52485754 |
| 114 | TRIM28 | 0.50338943 |
| 115 | PINK1 | 0.50261448 |
| 116 | BMX | 0.49988291 |
| 117 | CSNK2A1 | 0.49915617 |
| 118 | ERBB4 | 0.49319697 |
| 119 | RPS6KA5 | 0.48257407 |
| 120 | PIM2 | 0.47205661 |
| 121 | PTK2B | 0.45578693 |
| 122 | SMG1 | 0.44158571 |
| 123 | TSSK6 | 0.43822526 |
| 124 | MAP3K4 | 0.43727744 |
| 125 | CDK7 | 0.43582429 |
| 126 | MAPK15 | 0.42161622 |
| 127 | PRKD1 | 0.41425488 |
| 128 | PRKCG | 0.40845468 |
| 129 | PRKD3 | 0.40531812 |
| 130 | TYRO3 | 0.40050730 |
| 131 | ADRBK1 | 0.39971166 |
| 132 | IRAK2 | 0.39627940 |
| 133 | PRKACA | 0.39433319 |
| 134 | PRKG1 | 0.38065362 |
| 135 | PRKCQ | 0.37458088 |
| 136 | CSNK1A1 | 0.36150647 |
| 137 | FLT3 | 0.36058600 |
| 138 | DYRK3 | 0.36017424 |
| 139 | MAP2K2 | 0.35457215 |
| 140 | MAP3K9 | 0.35413893 |
| 141 | MKNK1 | 0.35287646 |
| 142 | PDPK1 | 0.35240952 |
| 143 | EPHB2 | 0.34898230 |
| 144 | STK4 | 0.34252293 |
| 145 | TRPM7 | 0.33614843 |
| 146 | WNK3 | 0.33281054 |
| 147 | PRKACB | 0.33142795 |
| 148 | PRKG2 | 0.32954034 |
| 149 | TESK1 | 0.31866359 |
| 150 | FYN | 0.31169341 |
| 151 | ROCK1 | 0.29874733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.94533882 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.43578781 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.15184865 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.42553626 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.36293896 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 3.19903323 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.01452086 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.93437185 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.73167817 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.70245898 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.62556783 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.61387774 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.37268826 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.26154783 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.22326807 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.20887227 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17678435 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 2.10229998 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.09014677 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07313009 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.89586090 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77332403 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71413289 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67262988 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65817039 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62635709 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.59079958 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49045597 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47998779 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.47441839 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46583220 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46263996 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.44542302 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.41453609 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40344615 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39516814 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.38422984 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34737351 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32305877 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31125102 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26812925 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23846322 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.23307184 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20746054 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20664697 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19114837 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10035947 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.08827760 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05782461 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.02790088 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02723790 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99549195 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.98231143 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95686931 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95517678 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93419857 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91728322 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 0.90303805 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90057681 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86661910 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86074960 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84783881 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84581726 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84434829 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83196073 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83018098 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82144653 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79829621 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79593413 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76135219 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76003395 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.75918439 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75399173 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74477059 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72312924 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.72202005 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.70785837 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69313710 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68931976 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68065198 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.66222450 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63321113 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62943080 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61202381 |
| 85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58587230 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.58175280 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57925300 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.56049742 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55556470 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.54547615 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54051452 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53820104 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.53503056 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52953158 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52545170 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51622919 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50323607 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49203353 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47752279 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46848874 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.46516876 |
| 102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43514919 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41706441 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.41504438 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.41244294 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40469610 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40127566 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39249976 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37892833 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37428334 |
| 111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37269660 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36575343 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35926608 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35528971 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34123898 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33072838 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33032746 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.32983685 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32982221 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32004410 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31931001 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31898409 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31281797 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.31071166 |
| 125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30938157 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29844313 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29105382 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.29037639 |
| 129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28445242 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.27901912 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27860524 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27419888 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27222605 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26728922 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25963133 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25668541 |
| 137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.25622102 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25091755 |
| 139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24436890 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23389092 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23346047 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22879220 |
| 143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22617364 |
| 144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21212682 |
| 145 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20816833 |
| 146 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18440538 |
| 147 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.18422912 |
| 148 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15068380 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14387918 |
| 150 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13135002 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12092642 |
| 152 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.10634428 |
| 153 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.09478251 |

